Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2016

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015
Numerator:
Net loss - basic and diluted	$	(5,696	)	$	(6,431	)	$	(20,412	)	$	(25,891	)

Denominator:
Weighted average common shares outstanding - basic and diluted		71,536			71,382			71,512			69,833

Net loss per share:
Basic	$	(0.08	)	$	(0.09	)	$	(0.29	)	$	(0.37	)
Diluted	$	(0.08	)	$	(0.09	)	$	(0.29	)	$	(0.37	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Share

The following outstanding warrants, options and purchase rights under the Company’s 2004 Employee Stock Purchase Plan (“2004 Purchase Plan”) were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2016		2015		2016		2015
Shares issuable upon exercise of warrants		8,300		12,136		8,300		12,136
Shares issuable upon exercise of stock options		11,128		10,287		11,128		10,287
Shares issuable related to the 2004 Purchase Plan		27		40		27		40